Prior to joining Revival, Todd was the President and CEO of TransEnterix, Inc. (NYSE MKT: TRXC),  a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment.

Prior to TransEnterix, Todd was the Global President of Johnson & Johnson Cordis where he led a multi-billion-dollar business unit comprised of 3 distinct companies; Cardiology, Neurovascular, and Peripheral Vascular.  Prior to his role at Cordis, Todd held executive positions as CEO of Liquidia Technologies, a nanotechnology-based healthcare company, in Research Triangle Park, North Carolina.  Prior to Liquidia,  Todd spent 14 years in various management roles with increasing levels of responsibility at both Johnson & Johnson’s Ethicon Endo-Surgery Division, and Boston Scientific where he rose to Vice President, Global Sales and Marketing, Neurovascular Division.